Safety Alert

Drug / group of drugs
Type of news
#Drug / group of drugsType of newsDateLink of news
1Switching between Warfarin Brands and The Importance of Close Monitoring of INRPrecautionsJune/2020 التفاصيل
2Hydroxychloroquine and Chloroquine Alone and in Combination with Azithromycin and Potential Increased Risk of Heart Rhythm ProblemsWarningMay/2020 التفاصيل
3SFDA Recommendations for Healthcare Professionals Regarding The Unapproved Use of Hydroxychloroquine and Chloroquine in Treatment of COVID-19WarningApril/2020 التفاصيل
4SFDA Advises Continued Use of Angiotensin-Converting Enzyme (ACE) Inhibitors and Angiotensin Receptor Blockers (ARBs) in Patients with COVID-19PrecautionsApril/2020 التفاصيل
5SFDA’s Advice on the Use of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) in Patients with COVID-19PrecautionsMarch/2020 التفاصيل
6Risk of potentially fatal respiratory depression with benzodiazepines and opioidsWarningMarch/2020 التفاصيل
7Concern on Potential Risk of Respiratory Depression Associated with Gabapentinoids (pregabalin and gabapentin) medicationsWarningJanuary/2020 التفاصيل
8Ceftriaxone: a reminder for the risk of hypersensitivityWarningDecember/2019 التفاصيل
9Concerns on paracetamol overdose in childrenWarningNovember/2019 التفاصيل
10Risk of neuropsychiatric reactions with the use of MontelukastWarningOctober/2019 التفاصيل